Guillain-Barré syndrome diagnostic criteria: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 28: | Line 28: | ||
[[Category:Neurology]] | [[Category:Neurology]] | ||
[[Category:Immunology]] | [[Category:Immunology]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Emergency medicine]] | [[Category:Emergency medicine]] | ||
[[Category:Infectious disease]] | [[Category:Infectious disease]] | ||
[[Category:Needs overview]] | [[Category:Needs overview]] | ||
Revision as of 15:47, 28 February 2013
|
Guillain-Barré syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Guillain-Barré syndrome diagnostic criteria On the Web |
|
American Roentgen Ray Society Images of Guillain-Barré syndrome diagnostic criteria |
|
Risk calculators and risk factors for Guillain-Barré syndrome diagnostic criteria |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Priyamvada Singh, MBBS [2]
Diagnostic Criteria
- Required
- Progressive, relatively symmetrical weakness of 2 or more limbs due to neuropathy
- Areflexia
- Disease course < 4 weeks
- Exclusion of other causes (see below)
- Supportive
- Relatively symmetric weakness accompanied by numbness and/or tingling
- Mild sensory involvement
- Facial nerve or other cranial nerve involvement
- Absence of fever
- Typical CSF findings obtained from lumbar puncture
- Electrophysiologic evidence of demyelination from electromyogram